Tue, August 6, 2024

Anupam Rama Maintained (SNDX) at Buy with Decreased Target to $33 on, Aug 6th, 2024

Anupam Rama of JP Morgan, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Decreased Target from $34 to $33 on, Aug 6th, 2024.

Anupam has made no other calls on SNDX in the last 4 months.



There are 5 other peers that have a rating on SNDX. Out of the 5 peers that are also analyzing SNDX, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Anupam


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $41 on, Friday, August 2nd, 2024
  • Jason Zemansky of "B of A Securities" Maintained at Strong Buy with Decreased Target to $30 on, Tuesday, July 30th, 2024
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $37 on, Friday, June 28th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Wednesday, June 26th, 2024
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Thursday, May 9th, 2024